Back to Browse Journals » International Journal of Nanomedicine » Volume 7

Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs

Authors Li YT, Chua MJ, Kunnath AP, Chowdhury EH

Published Date June 2012 Volume 2012:7 Pages 2473—2481

DOI http://dx.doi.org/10.2147/IJN.S30500

Received 2 February 2012, Accepted 17 March 2012, Published 5 June 2012

Yong Tsuey Li,1 Ming Jang Chua,1 Anil Philip Kunnath,1 Ezharul Hoque Chowdhury,1,2

1
Faculty of Medicine and Health Science, International Medical University (IMU), No 126, Jalan 19/155B, Bukit Jalil, 57000 Kuala Lumpur, Malaysia; 2Jeffrey Cheah School of Medicine and Health Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University Kuala Lumpur, Malaysia

Background: Multidrug resistance, a major impediment to successful cancer chemotherapy, is the result of overexpression of ATP-binding cassette (ABC) transporters extruding internalized drugs. Silencing of ABC transporter gene expression with small interfering RNA (siRNA) could be an attractive approach to overcome multidrug resistance of cancer, although delivery of siRNA remains a major hurdle to fully exploit the potential of siRNA-based therapeutics. Recently, we have developed pH-sensitive carbonate apatite nanoparticles to efficiently carry and transport siRNA across the cell membrane, enabling knockdown of the cyclin B1 gene and consequential induction of apoptosis in synergy with anti-cancer drugs.
Methods and results: We report that carbonate apatite-mediated delivery of the siRNAs targeting ABCG2 and ABCB1 gene transcripts in human breast cancer cells which constitutively express both of the transporter genes dose-dependently enhanced chemosensitivity to doxorubicin, paclitaxel and cisplatin, the traditionally used chemotherapeutic agents. Moreover, codelivery of two specific siRNAs targeting ABCB1 and ABCG2 transcripts resulted in a more robust increase of chemosensitivity in the cancer cells, indicating the reversal of ABC transporter-mediated multidrug resistance.
Conclusion: The delivery concept of multiple siRNAs against ABC transporter genes is highly promising for preclinical and clinical investigation in reversing the multidrug resistance phenotype of breast cancer.

Keywords: carbonate apatite, siRNA, gene expression, transfection, breast cancer, ABC transporter, multidrug resistance, chemosensitivity

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Stop the escalators: using the built environment to increase usual daily activity

John M Westfall, Doug H Fernald

Pragmatic and Observational Research 2010, 1:7-9

Published Date: 21 September 2010

Gene expression for HIV-associated dementia and HIV encephalitis in microdissected neurons 1: preliminary analysis

Shapshak P, Duncan R, Duran EM, Farinetti F, Minagar A, Commins D, Rodriguez H, Chiappelli F, Kangueane P, Levine AJ, Singer E, Somboonwit C, Sinnott JT

Neurobehavioral HIV Medicine 2011, 3:53-78

Published Date: 19 July 2011

Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies

Li B, Xu H, Li Z, Yao M, Xie M, Shen H, Shen S, Wang X, Jin Y

International Journal of Nanomedicine 2012, 7:187-197

Published Date: 9 January 2012

The association of C3435T single-nucleotide polymorphism, Pgp-glycoprotein gene expression levels and carbamazepine maintenance dose in patients with epilepsy

Sterjev Z, Trencevska GK, Cvetkovska E, Petrov I, Kuzmanovski I, Ribarska JT, Nestorovska AK, Matevska N, Naumovska Z, Jolevska-Trajkovic S, Dimovski A, Suturkova L

Neuropsychiatric Disease and Treatment 2012, 8:191-196

Published Date: 19 April 2012

In vitro cellular uptake of evodiamine and rutaecarpine using a microemulsion

Zhang YT, Huang ZB, Zhang SJ, Zhao JH, Wang Z, Liu Y, Feng NP

International Journal of Nanomedicine 2012, 7:2465-2472

Published Date: 18 May 2012

Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies

Lv LZ, Tong CQ, Lv Q, Tang XJ, Li LM, Fang QX, Yu J, Han M, Gao JQ

International Journal of Nanomedicine 2012, 7:4099-4107

Published Date: 30 July 2012

Antihyperalgesic activity of nucleoside transport inhibitors in models of inflammatory pain in guinea pigs

Maes SS, Pype S, Hoffmann VL, Biermans M, Meert TF

Journal of Pain Research 2012, 5:391-400

Published Date: 12 October 2012